Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer, will participate in …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its financial and operating results for the third quarter of 2021.
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and River Region Psychiatry Associates (RRPA) this week announced a partnership agreement under which Neuronetics will be the exclusive supplier of transcranial magnetic …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that it plans to release third quarter financial and operating results prior to market open on Tuesday, November 9, 2021. The Company …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a leading provider, Success TMS, has reached an impressive milestone delivering over 235,000 NeuroStar transcranial magnetic stimulation (TMS) treatments to patients across …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced the release of the latest evolution of their NeuroStar® Advanced Therapy system with upgraded equipment and features. NeuroStar® Advanced Therapy for Mental …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week provided preliminary revenue results for the third quarter of 2021.
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a recent commercial agreement with Success TMS in which Success TMS will exclusively utilize Neuronetics’ platform, NeuroStar Advanced Therapy for Mental Health, …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced new partnerships with mental health advocates and organizations in honor of National Depression Education and Awareness Month and Mental Illness Awareness Week. …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
Read More